258 related articles for article (PubMed ID: 19664641)
21. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
[TBL] [Abstract][Full Text] [Related]
22. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
[TBL] [Abstract][Full Text] [Related]
24. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
25. Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription.
Kusano S; Eizuru Y
Biochem Biophys Res Commun; 2013 Apr; 433(4):438-44. PubMed ID: 23501106
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
28. CCR5 signaling through phospholipase D involves p44/42 MAP-kinases and promotes HIV-1 LTR-directed gene expression.
Paruch S; Heinis M; Lemay J; Hoeffel G; Marañón C; Hosmalin A; Périanin A
FASEB J; 2007 Dec; 21(14):4038-46. PubMed ID: 17627030
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
West MJ; Karn J
EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
[TBL] [Abstract][Full Text] [Related]
30. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
31. Transient-mediated fate determination in a transcriptional circuit of HIV.
Weinberger LS; Dar RD; Simpson ML
Nat Genet; 2008 Apr; 40(4):466-70. PubMed ID: 18344999
[TBL] [Abstract][Full Text] [Related]
32. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
[TBL] [Abstract][Full Text] [Related]
33. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
[TBL] [Abstract][Full Text] [Related]
34. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
[TBL] [Abstract][Full Text] [Related]
35. Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolic phytostilbene.
Lee EO; Kim SE; Park HK; Kang JL; Chong YH
Exp Neurol; 2011 Jun; 229(2):399-408. PubMed ID: 21419119
[TBL] [Abstract][Full Text] [Related]
36. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat.
Emilie D; Maillot MC; Nicolas JF; Fior R; Galanaud P
J Biol Chem; 1992 Oct; 267(29):20565-70. PubMed ID: 1400376
[TBL] [Abstract][Full Text] [Related]
39. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
[TBL] [Abstract][Full Text] [Related]
40. Metabolic benefits from Sirt1 and Sirt1 activators.
Chaudhary N; Pfluger PT
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
